Second-Line Intraperitoneal Platinum-Based Therapy Leads to an Increase in Second-Line Progression-Free Survival for Epithelial Ovarian Cancer EDITORIAL COMMENT

被引：0
|
作者：
Van Le, Linda
机构：
来源：
OBSTETRICAL & GYNECOLOGICAL SURVEY | 2016年 / 71卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：468 / 469
页数：3
相关论文
共 50 条
  • [21] Second-line therapy in colorectal cancer
    Berlin, J
    ONCOLOGY-NEW YORK, 2000, 14 (12): : 21 - 26
  • [22] Second-line therapy in bladder cancer
    Bachner, Mark
    De Santis, Maria
    CURRENT OPINION IN UROLOGY, 2009, 19 (05) : 533 - 539
  • [23] Progression-free survival in first-line chemotherapy is a prognostic factor in second-line chemotherapy in patients with advanced gastric cancer
    Kenji Hashimoto
    Atsuo Takashima
    Kengo Nagashima
    Shun-suke Okazaki
    Takako Eguchi Nakajima
    Ken Kato
    Tetsuya Hamaguchi
    Yasuhide Yamada
    Yasuhiro Shimada
    Journal of Cancer Research and Clinical Oncology, 2010, 136 : 1059 - 1064
  • [24] Progression-free survival in first-line chemotherapy is a prognostic factor in second-line chemotherapy in patients with advanced gastric cancer
    Hashimoto, Kenji
    Takashima, Atsuo
    Nagashima, Kengo
    Okazaki, Shun-suke
    Nakajima, Takako Eguchi
    Kato, Ken
    Hamaguchi, Tetsuya
    Yamada, Yasuhide
    Shimada, Yasuhiro
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2010, 136 (07) : 1059 - 1064
  • [25] Timing for starting second-line therapy in recurrent ovarian cancer
    Guarneri, Valentina
    Barbieri, Elena
    Dieci, Maria Vittoria
    Piacentini, Federico
    Conte, PierFranco
    EXPERT REVIEW OF ANTICANCER THERAPY, 2011, 11 (01) : 49 - 55
  • [26] Second-line therapy of advanced ovarian cancer with GnRH analogs
    Balbi, G
    Piano, LD
    Cardone, A
    Cirelli, G
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2004, 14 (05) : 799 - 803
  • [27] Gemcitabine and carboplatin in second-line ovarian cancer
    Ozols, RF
    SEMINARS IN ONCOLOGY, 2005, 32 (04) : S4 - S8
  • [28] Second-line treatment with Topotecan in ovarian cancer
    Morales, S
    Balil, A
    Salud, A
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S87 - S87
  • [29] Long progression-free survival with first-line paclitaxel plus platinum is associated with improved response and progression-free survival with second-line docetaxel in advanced non-small-cell lung cancer
    Eleazar Omar Macedo-Pérez
    Vicente Morales-Oyarvide
    Víctor Osvaldo Mendoza-García
    Yuzmiren Dorantes-Gallareta
    Diana Flores-Estrada
    Oscar Arrieta
    Cancer Chemotherapy and Pharmacology, 2014, 74 : 681 - 690
  • [30] Long progression-free survival with first-line paclitaxel plus platinum is associated with improved response and progression-free survival with second-line docetaxel in advanced non-small-cell lung cancer
    Omar Macedo-Perez, Eleazar
    Morales-Oyarvide, Vicente
    Osvaldo Mendoza-Garcia, Victor
    Dorantes-Gallareta, Yuzmiren
    Flores-Estrada, Diana
    Arrieta, Oscar
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 74 (04) : 681 - 690
12345